Jason Andrade
banner
drjasonandrade.bsky.social
Jason Andrade
@drjasonandrade.bsky.social
Director of Cardiac Electrophysiology VGH / Clinical Faculty UBC / Co-Chair CCS AF Guidelines / CHRS Device Chair
I’ve argued this “ideological” conflict of interest is much more problematic than the “perceived” financial conflicts that are routinely disclosed

When being a contrarian brings acclaim and financial reward you tend to move behaviour towards actions that reinforce the outcome

It’s like pop music
February 28, 2025 at 10:10 PM
The shorter blanking will enable earlier intervention to improve clinical outcomes (eg, early reablation) at the expense of potentially overtreating a minority of patients (4%) with a low burden of AF.

www.ahajournals.org/doi/10.1161/...
February 20, 2025 at 4:19 PM
Perhaps more interesting is the observation that failure timing and burden were interrelated.

Those who failed earlier (e.g. month 3) had nearly 20x higher burden than those that failed later (after month 3).
February 20, 2025 at 4:19 PM
We found:
1. A shorter blanking period lowered the one-year freedom from atrial tachyarrhythmia to 49.6% (8 week blanking) from 53.7% (12 week blanking), but
2. The median AF burden in patients with arrhythmia recurrence did not differ between an 8- and 12-week blanking period (0.18% vs 0.23%).
February 20, 2025 at 4:19 PM
We to investigate the clinical implications of a shortened blanking period on arrhythmia-free survival and AF burden in the CIRCA-DOSE cohort as this population had implantable monitors with all episodes following ablation being independently adjudicated.

www.ahajournals.org/doi/full/10....
American Heart Association Journals
www.ahajournals.org
February 20, 2025 at 4:19 PM
Recently the 2024 EHRA/HRS/APHRS/LAHRS expert consensus statement on catheter and surgical ablation of atrial fibrillation shortened the blanking period from 12w to 8w.
academic.oup.com/europace/art...
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial...
Abstract. In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based safe and efficacious treatment for managing the most
academic.oup.com
February 20, 2025 at 4:19 PM
Early arrhythmia recurrences following AF ablation are frequent and negatively impact patient outcomes.

As most early recurrences are transient, it is common to use a postprocedural blanking period, whereby recurrences don’t count as treatment failure.

onlinelibrary.wiley.com/doi/10.1111/...
Early Recurrence of Atrial Tachyarrhythmias Following Radiofrequency Catheter Ablation of Atrial Fibrillation
The use of blanking periods, the immediate period postablation during which transient tachyarrhythmia episodes are not considered recurrences, has been predicated on the assumption that not all early...
onlinelibrary.wiley.com
February 20, 2025 at 4:19 PM
I dislike the book, but rule 10.

“If you don't take a temperature, you can't find a fever”
February 16, 2025 at 8:46 PM
Remarkably these trials show a very consistent result, catheter ablation was associated with a 85% reduction in the rate of progression to more advanced forms of AF (eg persistent AF).

Meaning we now have an intervention that is disease modifying.

www.heartrhythmjournal.com/article/S154...
January 7, 2025 at 2:51 PM
But observational evidence doesn't tell us about treatment effects, so the issue remained unresolved until recently

In the past few years we have seen 5 RCTs compare pharmacotherapy to catheter ablation as a first, second, or third line therapy

www.nejm.org/doi/full/10....
January 7, 2025 at 2:51 PM
But studies (and clinical management) tends to focus merely on the recurrence of arrhythmia, often not considering that our interventions can be disease modifying.

For example, observational evidence suggested progression was greatest in those treated with rate control…
January 7, 2025 at 2:51 PM